Onward Assist: Revolutionizing Cancer Diagnosis with AI-Powered Pathology Tools

Onward Assist is a cutting-edge, full-stack AI platform designed for pathologists and healthcare professionals, offering advanced cancer analytics through a suite of intelligent tools including PathAssist, PathFlowDx, Slide Scholar, and LabNetX. Built with proprietary AI algorithms and optimized for digital pathology workflows, it accelerates cancer diagnosis by identifying biomarkers with precision, reduces reporting time by 30–40%, and supports research, second opinions, telepathology, and cross-specialty collaboration. The platform is highly adaptable, enabling secure cloud or on-premises deployment, and integrates seamlessly with existing IT systems, WSI scanners, LIMS, and EMRs. With a strong focus on accuracy, accessibility, and clinical relevance, Onward Assist empowers pathologists to deliver faster, more reliable results while fostering academic training and operational efficiency in labs.

Key Features:

• PathAssist AI Engine: Proprietary AI for analyzing digital pathology slides and predicting cancer metrics with high speed and accuracy.
• Multiple AI Algorithms: Offers 6 research-grade algorithms with options tailored to organ type, tumor site, or specific biomarkers; supports integration of third-party algorithms.
• PathFlowDx Workflow Management: Web-based system for managing digital pathology workflows, case allocation, status tracking, and collaborative tumor board discussions.
• Slide Scholar Academic Training Platform: Intuitive, cloud-accessible environment for contextual learning, slide annotation, and building expertise in digital pathology.
• LabNetX Lab Management System: Cloud-based tool for managing RT-PCR and microscopy lab operations, sample tracking, customizable dashboards, and report templating.
• Seamless Integration: Compatible with mainstream WSI formats, digital scanners, LIMS, EMRs, and lab machines; integrates easily with existing infrastructure.
• Flexible Deployment: Available in secure cloud or on-premises environments for enhanced data control and compliance.
• User-Friendly Interface: Fast load times, intuitive navigation, and streamlined workflows for efficient daily use.
• Collaborative Tools: Supports multi-user access and shared annotation for team-based diagnostics and training.
• Clinical & Research Use: Designed for both clinical reporting and academic research, with support for real-world applications across oncology and diagnostics.
• CE Certified: Ensures safety and compliance for digital pathology systems.
• Free Trial & Demo Access: Available upon registration or request to experience the platform’s capabilities.

Pricing: Onward Assist offers flexible pricing models, including subscription-based, pay-per-use, and customized enterprise plans, tailored to partner needs and usage scale. Free trial access is available to evaluate the platform.

Conclusion: Onward Assist stands at the forefront of computational pathology, combining powerful AI analytics with intuitive workflow and training tools to transform cancer diagnosis—making it faster, more accurate, and accessible for pathologists, researchers, and healthcare institutions worldwide.